Core Insights - QIAGEN N.V. announced its third quarter 2025 results and reaffirmed its outlook for solid profitable growth while raising profitability targets [1] - The company expects net sales growth of approximately 4-5% CER for FY 2025, with core sales growth (excluding divestments) projected at about 5-6% CER [1] - QIAGEN raised its adjusted diluted EPS target to approximately $2.38 CER, up from the previous target of about $2.35 CER [1] Financial Performance - QIAGEN's third quarter results indicate a strong performance, contributing to the positive outlook for the remainder of FY 2025 [1] - The adjusted operating performance is expected to align with the raised profitability targets, reflecting the company's commitment to growth [1]
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase